Jupiter Life Line Hospitals Ltd
Acquistion of shares
M&A
▲ Positive Development
LOW RISK
📅 Filed on BSE: 31 Jul 2026, 05:31 PM IST · BSE ID: 5a69f9bf-313b-401e-b8a2-0126573cc7ac
View Original BSE Filing (PDF)
💡
In Simple Terms
The company released its quarterly earnings, appointed a new CFO, and its subsidiary bought another company for ₹3.78 crore.
🤖 AI Summary
- Board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
- Mr. Harshad Purani appointed Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) effective July 31, 2026.
- Jupiter Hospital Pharmacy Private Limited (JHPPL) acquired 100% equity of Sulcus Private Limited for ₹3.78 crore.
- Sulcus Private Limited is now a wholly owned subsidiary of JHPPL and a step-down subsidiary of Jupiter Life Line Hospitals Ltd.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Revenue from operations (Q1 FY27)
3,284.85
Standalone Revenue from operations (Q1 FY26)
2,119.87
Standalone Net Profit After Tax (Q1 FY27)
395.04
Standalone Net Profit After Tax (Q1 FY26)
130.40
Acquisition Cost for Sulcus Private Limited
₹3.78 crore
🏢 How This Affects the Company
The acquisition of Sulcus Private Limited through a subsidiary expands the company's operational footprint, making Sulcus a new step-down subsidiary.
The company's subsidiary incurred ₹3.78 crore for the acquisition, which will reflect in consolidated financial statements.
The addition of Sulcus Private Limited as a step-down subsidiary integrates its operations into the broader corporate structure.
The appointment of a new CFO brings changes to the financial leadership and oversight functions within the company.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this filing.
👤
Who Is Affected
Shareholders are indirectly affected by the company's financial performance, the new CFO appointment, and the expansion of its subsidiary structure through the ₹3.78 crore acquisition.
🔍
Management Signal
Management is focusing on strategic growth through acquisitions and strengthening financial leadership with a new CFO appointment.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 financial results — review consolidated performance after acquisition.
Further updates on integration of Sulcus Private Limited into operations.
Any future announcements regarding new strategic investments or acquisitions.
LOW RISK
The filing indicates routine business operations and strategic expansion without immediate significant risks.
💡 Investor Takeaway
Jupiter Life Line Hospitals Ltd reported standalone Revenue from operations of 3,284.85 for Q1 FY27, up from 2,119.87 YoY. Net Profit After Tax stood at 395.04 for Q1 FY27, compared to 130.40 YoY. A subsidiary acquired Sulcus Private Limited for ₹3.78 crore, and a new CFO was appointed.
⚖️ Strengths & Concerns
✅ Positives
- Standalone Revenue from operations increased to 3,284.85 for quarter ended June 30, 2026, from 2,119.87 for June 30, 2025.
- Net Profit After Tax (Standalone) increased to 395.04 for quarter ended June 30, 2026, from 130.40 for June 30, 2025.
⚠️ Concerns
- Other income decreased to 106.43 for quarter ended June 30, 2026, from 128.36 for June 30, 2025.
- The unaudited standalone financial results include a share of net loss after tax of Rs. 3.24 million from a partnership firm for the quarter ended June 30, 2025.
📅 Company Track Record
No previous filings were found for Jupiter Life Line Hospitals Ltd in the provided context. The company's IPO was in September 2023, making it a recently listed entity with a limited public track record available prior to FY27.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What were Jupiter Life Line Hospitals' standalone revenues for Q1 FY27?
Jupiter Life Line Hospitals reported standalone Revenue from operations of 3,284.85 for the quarter ended June 30, 2026.
Who was appointed as the new Chief Financial Officer for Jupiter Life Line Hospitals?
Mr. Harshad Purani was appointed as the Chief Financial Officer and Key Managerial Personnel of Jupiter Life Line Hospitals, effective July 31, 2026.
What was the acquisition cost for Sulcus Private Limited by Jupiter Hospital Pharmacy Private Limited?
Jupiter Hospital Pharmacy Private Limited, a subsidiary, acquired 100% of the equity share capital of Sulcus Private Limited for a consideration of ₹3.78 crore.
What was the standalone Net Profit After Tax for Jupiter Life Line Hospitals in Q1 FY27?
The standalone Net Profit After Tax for Jupiter Life Line Hospitals was 395.04 for the quarter ended June 30, 2026.
Questions based on this BSE filing only. For information purposes.